Abbott Announces Health Canada Authorization Under the COVID-19 Interim Order and Immediate Availability of its COVID-19 Antibody Test in Canada View more
ABBOTT RECEIVES FDA EMERGENCY USE AUTHORIZATION FOR COVID-19 MOLECULAR TEST ON NEW ALINITY™ M SYSTEM View more
ABBOTT RECEIVES FDA EMERGENCY USE AUTHORIZATION FOR COVID-19 ANTIBODY BLOOD TEST ON ALINITY™ I SYSTEM View more
